Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02790385
Other study ID # H13-03020
Secondary ID
Status Recruiting
Phase Phase 0
First received February 7, 2014
Last updated May 30, 2016
Start date July 2014
Est. completion date July 2019

Study information

Verified date May 2016
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Children with neuromuscular disorders such as cerebral palsy, children with kyphosis and post-traumatic scoliosis have higher infection rates after scoliosis surgery than healthy children who undergo scoliosis surgery. The purpose of our study is to compare the effect of NPWT on infection rates when compared to standard gauze dressing. Participants will be randomized to the "NPWT" or "standard dressing" group. We will compare infection rates between the two groups. We hypothesize participants in the "NPWT" group will have a lower infection rate.


Recruitment information / eligibility

Status Recruiting
Enrollment 870
Est. completion date July 2019
Est. primary completion date July 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 8 Years to 21 Years
Eligibility Inclusion Criteria:

- Male or female

- Consent/assent to participate in the study

- Undergoing posterior spinal surgery categorized as High-Risk for infection, defined as greater than 4% risk of deep or superficial infection based previous reported literature. Procedures qualifying for study are listed below:

- Kyphosis (any type)

- Posttraumatic Scoliosis

- Neuromuscular Scoliosis

Exclusion Criteria:

- Previous incisions over the operative site

- History of keloid formation

- Allergy to tape

- Does not consent/assent to participate in the study

- Previous or Active Spinal infection

- Dural tear

- Hemophiliac

- Two Stage procedure

- Unable to follow standard antibiotic protocols

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • to See Whether Negative Pressure Wound Therapy Decreases Wound Infections.
  • Wound Infection

Intervention

Device:
Negative Pressure Wound Therapy

Other:
Standard Gauze Treatment


Locations

Country Name City State
Canada BC Children's Hospital Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wound Infection Wounds will be classified as prolonged discharge if they have persistent sterile drainage on post-op day 5 or after, or as "infected," if cellulitis is found at suture line (erythema >1cm + tenderness + localized swelling + warmth). Wound assessment will be carried out by a clinical fellow on day 5 and subsequent days till discharge. Patients will also be assessed for other signs of infection such as Fever, Chills, and increase in pain or changes in appetite. Standard infection work-up will be utilized to rule in or rule out infection. up to post op day 14 No
Secondary Time for wound closure This will be measured intra-operatively in the operating room from the beginning of deep wound closure till complete skin closure either with standard treatment or by NPWT. Though this outcome measure may not appear to have much value as these surgeries are of a long duration, we considered it important from the surgeon's perspective. intraoperatively No
Secondary Cosmetic results (Hollander wound evaluation scale): This is a validated cosmetic scoring system [8], which gives a score from 0 to 6. The score addresses six clinical variables: step off borders, contour irregularities, scar width, edge inversion, excessive inflammation, and overall cosmetic appearance. Each of these categories is graded on a 0- or 1-point scale where a score of 6 is considered optimal. At 12 weeks post-op follow-up, assessment of the scar will be carried out by an independent investigator who will be blinded to which treatment group the patient belongs to. 12 weeks post op No
Secondary Caregiver/parental satisfaction This will analyzed on a visual analog scale (VAS) 12 weeks post op No
Secondary Wound dehiscence Any gaping of the spinal wound > 5cm exposing subcutaneous tissue or deeper planes will be considered as indicative of wound dehiscence. This will be looked for at the 5th post- operative day during dressing change till 14 days post-op. psot op day 5 to discharge Yes
Secondary Foreign body reaction Any evidence of foreign body reaction will be looked for at the two week mark and at 12 weeks post-op follow up. The presence of swelling under the wound over the suture or NPWT site in the absence of fever, significant redness and tenderness will be indicative of foreign body reaction. 12 weeks post op Yes